Many patients with hyperthyroidism relapse following cessation of the antithyroid drug methimazole. Paradoxically, treatment of relapsed hyperthyroidism with radioiodine frequently causes ...

Boca Pharmacal has received approval from the FDA for Methimazole Tablets USP, the generic version of King Pharmaceutical‘s Tapazole tablets. Methimazole is an antithyroid agent indicated to treat ...

Agranulocytosis is the most severe adverse effect of antithyroid drug therapy. The findings of a novel study from Japan suggest that this complication occurs more frequently if higher rather than ...

A 35-year-old Asian male was diagnosed as hyperthyroid (time zero) when he presented with symptoms of sweating, palpitations, and a weight loss of 20 pounds (down to 85 pounds, (5 feet, 5 inches tall) ...

Co announces the FDA has granted final approval for the co's Abbreviated New Drug Application for Methimazole Tablets USP, 5 mg and 10 mg. The co's Methimazole is therapeutically equivalent to the FDA ...

Whether the hyperthyroidism is due to Graves' disease, MNG, or an autonomous nodule, in the short term it is reasonable to render the patient euthyroid with an antithyroid agent. Propylthiouracil (PTU ...